Adjuvant systemic therapy in high-risk breast cancer: the Danish Breast Cancer Cooperative Group's trials of cyclophosphamide or CMF in premenopausal and tamoxifen in postmenopausal patients.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples